Use of anti-psychotic drugs by people with dementia 'under reported'

October 17, 2012

The scale of the challenge to reduce the use of anti-psychotic drugs by people with dementia may be under-estimated, according to researchers from Aston University and the University of East Anglia, working with NHS Kent and Medway.

There is a key public health challenge to reduce the prescribing of to people with dementia as they are thought to be associated with up to 1,800 deaths a year.

Ian Maidment, corresponding author and a Senior Lecturer in from Aston University has worked in medication management in dementia for 20 years.

He said: "The true scale of anti-psychotic usage in dementia may be under-estimated. Usage may be up to 46 per cent greater than official figures suggest."

The researchers compared the results of the government's National Dementia and Anti-Psychotic Prescribing Audit with research, led by Anne Child, an experienced senior clinical pharmacist for NHS Kent and Medway cluster of primary care trusts (PCTs).

They found that 15.3 per cent of people with dementia received an anti-psychotic, compared to the national audit, which found 10.5 per cent. However, only 48.9 per cent of GP practices across the country participated in the national audit compared with 98.3 per cent of practices in Medway which took part in the detailed local study.

The Medway project, carried out from January to December 2011, and analysed by researchers from Aston University and the University of East Anglia, identified that:

  • People with dementia living in care homes were nearly 3.5 times more likely to receive a low-dose anti-psychotic than people living at home (25.5 per cent compared to 7.3 per cent)
  • It was possible to reduce or withdraw low-dose anti-psychotics for more than 60 per cent of patients with dementia (43 out of 70) whose medication was initiated by their GP.
  • Clinical trials need to be commissioned as a matter of urgency to confirm the effectiveness of pharmacist medication reviews.
The paper, which appears in the BioMed Central's open access journal BMC Psychiatry, also sets out the detailed process undertaken before and during withdrawal of anti-psychotics from patients.

Anne Child, primary author, who is now head of Pharmaceutical Care at Avante Care said: "We have demonstrated that a multi-disciplinary approach to dementia care, involving a pharmacy-led medication review, GPs, and care homes, can produce a positive outcome for patients, in one region of the country. More work is now needed."

Dr Chris Fox, co-author, from UEA's Norwich Medical School said: "Another issue with the national audit is it fails to report the usage of the drug lorazepam, which is sometimes used instead of anti-psychotics. It is potentially equally dangerous. Until we capture the true level of usage of all these drugs we cannot truly understand the issue."

Ian Maidment added: "Whilst the national audit is an important first step, it presents a partial picture. If we rely on it, exclusively we are doing a disservice to people with , their carers and their families."

Explore further: Reassurance for dementia sufferers on impact of common drugs

More information: www.biomedcentral.com/content/ … 1471-244X-12-155.pdf

Related Stories

Reassurance for dementia sufferers on impact of common drugs

September 18, 2011
Researchers whose findings on the detrimental impact of some common medicines on elderly people were widely reported earlier in the summer have found that taking a few of these medicines does not appear to cause further cognitive ...

Humor as effective as medication in treating agitation in dementia

September 21, 2011
Humour therapy is as effective as widely used antipsychotic drugs in managing agitation in patients with dementia – and avoids serious drug side effects, a new study shows.

People with dementia less likely to return home after stroke

October 31, 2011
New research shows people with dementia who have a stroke are more likely to become disabled and not return home compared to people who didn't have dementia at the time they had a stroke. The study is published in the November ...

Study calls for reviews of psychotropic medication use in elderly

September 13, 2012
(Medical Xpress)—Regular clinical reviews of psychotropic medication should be established in all care homes to promote safe and effective prescribing to an at-risk population of elderly people, according to a new study ...

Older people with dementia cared for mostly at home

May 11, 2012
(HealthDay) -- Many elderly people with dementia live and die at home rather than in nursing homes, a new study has found.

Recommended for you

Alzheimer's Tau protein forms toxic complexes with cell membranes

November 22, 2017
The brains of patients with Alzheimer's disease contain characteristic tangles inside neurons. These tangles are formed when a protein called Tau aggregates into twisted fibrils. As a result, the neurons' transport systems ...

Researchers reveal new details on aged brain, Alzheimer's and dementia

November 21, 2017
In a comprehensive analysis of samples from 107 aged human brains, researchers at the Allen Institute for Brain Science, UW Medicine and Kaiser Permanente Washington Health Research Institute have discovered details that ...

Dementia study sheds light on how damage spreads through brain

November 20, 2017
Insights into how a key chemical disrupts brain cells in a common type of dementia have been revealed by scientists.

Researchers describe new biology of Alzheimer's disease

November 20, 2017
In a new study, researchers from Boston University School of Medicine (BUSM) describe a unique model for the biology of Alzheimer's disease (AD) which may lead to an entirely novel approach for treating the disease. The findings ...

Study shows video games could cut dementia risk in seniors

November 16, 2017
Could playing video games help keep the brain agile as we age?

New player in Alzheimer's disease pathogenesis identified

November 14, 2017
Scientists at Sanford Burnham Prebys Medical Discovery Institute (SBP) have shown that a protein called membralin is critical for keeping Alzheimer's disease pathology in check. The study, published in Nature Communications, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.